Back

The protein APRIL predicts adverse outcomes in DAPT patients better than NT-proBNP and troponin

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Acute Coronary Syndromes: Biomarkers Biomarkers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Chris Pemberton

University of Otago Christchurch, Christchurch (New Zealand)

6 More presentations in this session

Presentation thumbnail
Professor D. Harrington (Irvine, US)
Abstract Slides
Presentation thumbnail
Doctor Z. Zhao (Fuzhou, CN)
Presentation thumbnail
Ms R. Hoogeveen (Amsterdam, NL)
Abstract
Presentation thumbnail
Doctor M. Lehrke (Aachen, DE)
Abstract
Presentation thumbnail
Doctor K. watthanasuntorn (Cooperstown, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Acute Coronary Syndromes: Biomarkers

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic significance of novel serum biomarkers in patients with acute coronary syndrome
27 August 2021
thumbnail
Congress Presentation
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis
21 March 2026
thumbnail
Congress Presentation
Predictive utility of apelin to nt-pro-brain natriuretic peptide ratio for heart failure with preserved ejection fraction among type 2 diabetes mellitus patients
29 June 2021
thumbnail
Congress Presentation
Direct comparison of the accuracy of preoperative high-sensitivity cardiac troponin T to predict mortality, acute heart failure and perioperative myocardial infarction/injury after non-cardiac surgery
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources